Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 2, 2022 | Post-IPO Equity | $5M | — | — | — | Detail |
| Aug 29, 2022 | Post-IPO Equity | $6.20M | — | — | — | Detail |
| May 17, 2022 | Post-IPO Equity | $2M | — | — | — | Detail |
| Feb 24, 2022 | Post-IPO Equity | $10M | — | — | — | Detail |
| Dec 28, 2021 | Post-IPO Equity | $4.20M | — | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Marathon Asset Management
|
Yes | Post-IPO Debt |